Zydus Lifesciences Limited
ZYDUSLIFE
Xếp hạng trong cổ phiếu
#1749
Zydus Lifesciences Limited, an Indian enterprise founded in Ahmedabad in 1952,... Zydus Lifesciences Limited, an Indian enterprise founded in Ahmedabad in 1952, operates globally in the pharmaceutical and consumer goods sectors. Renamed from Cadila Healthcare Limited in February 2022, the company manages the entire lifecycle of pharmaceutical products, from research and development to manufacturing, marketing, and distribution. Its extensive reach covers India, the United States, Europe, Latin America, the Asia Pacific region, and Africa. The company's pharmaceutical division provides a broad spectrum of offerings, including finished dosage human formulations (such as generics, branded generics, and specialized treatments like biosimilars and vaccines), as well as active pharmaceutical ingredients (APIs). Zydus focuses on therapeutic areas like pain management, neurology, dermatology, and liver diseases, among others. Additionally, it is developing a pipeline of biological products aimed at conditions such as oncology, autoimmune disorders, nephrology, ophthalmology, inflammation, rheumatology, hepatology, and infectious diseases. In its consumer products segment, Zydus offers popular wellness brands including Complan, the EverYuth range of skincare products, Nycil, Glucon-D glucose powder, Nutralite, and the Nutralite Doodhshakti dairy product line. Beyond these core operations, the company is also involved in investment activities, animal health and veterinary services, pharmacy retail, and human resource supply and administration.
Giá cổ phiếu
$12.30
Vốn hóa thị trường
$12.27B
Thay đổi (1 ngày)
0.06%
Thay đổi (1 năm)
8.33%
Quốc gia
IN
Giao dịch Zydus Lifesciences Limited (ZYDUSLIFE)
Danh mục
Healthcare
Tỷ lệ P/S của Zydus Lifesciences Limited (ZYDUSLIFE)
Tỷ lệ P/S vào October 2026 TTM: 3.94
Theo các báo cáo tài chính và giá cổ phiếu mới nhất của Zydus Lifesciences Limited, tỷ lệ P/S hiện tại (TTM) là 3.94. Vào cuối năm 2024, công ty có P/S là 5.18.
Lịch sử tỷ lệ P/S của Zydus Lifesciences Limited từ 2004 đến 2026
Tỷ lệ P/S vào cuối mỗi năm
| Năm | Tỷ lệ P/S | Thay đổi |
|---|---|---|
| 2026 (TTM) | 3.94 | 3.72% |
| 2025 | 3.80 | -26.59% |
| 2024 | 5.18 | 74.98% |
| 2023 | 2.96 | 22.93% |
| 2022 | 2.41 | -23.84% |
| 2021 | 3.16 | 59.50% |
| 2020 | 1.98 | -28.35% |
| 2019 | 2.76 | -18.65% |
| 2018 | 3.40 | -29.18% |
| 2017 | 4.80 | 45.51% |
| 2016 | 3.30 | -20.00% |
| 2015 | 4.12 | 41.90% |
| 2014 | 2.91 | 22.44% |
| 2013 | 2.37 | -22.24% |
| 2012 | 3.05 | -15.77% |
| 2011 | 3.62 | 18.07% |
| 2010 | 3.07 | 136.85% |
| 2009 | 1.30 | -0.58% |
| 2008 | 1.30 | -40.68% |
| 2007 | 2.20 | -59.66% |
| 2006 | 5.45 | 25.08% |
| 2005 | 4.35 | -50.77% |
| 2004 | 8.84 | 0.00% |
Tỷ lệ P/S của các công ty tương tự hoặc đối thủ cạnh tranh
| Công ty | Tỷ lệ P/S | Chênh lệch Tỷ lệ P/S | Quốc gia |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 79.07% |
IN
|
